Please use this identifier to cite or link to this item:
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5210Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Thorat, Shridhar H. | en_US |
| dc.contributor.author | Patwadkar, Manjusha V. | en_US |
| dc.contributor.author | Gonnade, Rajesh G. | en_US |
| dc.contributor.author | VAIDHYANATHAN, RAMANATHAN | en_US |
| dc.date.accessioned | 2020-10-20T07:06:50Z | - |
| dc.date.available | 2020-10-20T07:06:50Z | - |
| dc.date.issued | 2014-10 | en_US |
| dc.identifier.citation | Crystengcomm, 16(37), 8638-8641. | en_US |
| dc.identifier.issn | 1466-8033 | en_US |
| dc.identifier.uri | http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5210 | - |
| dc.identifier.uri | https://doi.org/10.1039/C4CE01446D | en_US |
| dc.description.abstract | Gefitinib, a life-extending anticancer drug, exhibits solvent-mediated conformational polymorphism to yield stable (form I) and novel metastable (form II) polymorphs. Crystal structure analysis revealed 3D isostructurality in the molecular organization of the polymorphs, and the metastable polymorph undergoes a crystal-to-crystal thermal phase transition to the stable polymorph. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Royal Society of Chemistry | en_US |
| dc.subject | Chemistry | en_US |
| dc.subject | 2014 | en_US |
| dc.title | Capturing a novel metastable polymorph of the anticancer drug gefitinib | en_US |
| dc.type | Article | en_US |
| dc.contributor.department | Dept. of Chemistry | en_US |
| dc.identifier.sourcetitle | Crystengcomm | en_US |
| dc.publication.originofpublisher | Foreign | en_US |
| Appears in Collections: | JOURNAL ARTICLES | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.